Igentify

Company Overview

Snapshot

Founded in October 2016 by Doron Behar and Galit Delmar, Igentify operates with 51–200 employees. The company has raised $38.36M across 8 funding rounds from 6 investors.

Business overview

Igentify is a digital health company that develops a digital platform for genetic test providers. Its core technology, the Digital Genetic Counselor, offers a scalable, end-to-end genetic counseling solution for both clinical and direct-to-consumer genetic testing applications. The platform supports various genotyping technologies, including microarray and next-generation sequencing (NGS), and provides personalized genetic counseling to consumers, serving markets in the United States and Europe within the Health Tech & Life Sciences sector.

Strategic signal

In October 2022, Igentify released Version 7 of its Digital Genetic Engine, a significant update aimed at scaling genetic counseling to meet increasing demand. This signals the company's continued investment in product development and its commitment to enhancing the accessibility and efficiency of genetic counseling services, which is crucial for market expansion and adoption in the digital health landscape.

Company Intelligence Q&A

When did Igentify release Version 7 of its Digital Genetic Engine?

Igentify released Version 7 of its Digital Genetic Engine in October 2022, focusing on scaling genetic counseling to meet demand.

Did Igentify announce any strategic collaborations recently?

In November 2020, Igentify announced a strategic collaboration with Genosity to integrate their offerings, aiming to provide a comprehensive precision medicine solution for health systems.